COMMUNIQUÉS West-GlobeNewswire

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
12/03/2026
COPENHAGEN, Denmark, March 12, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial [...]
Koelis annonce, à l’occasion du Congrès de l’EAU 2026, des innovations technologiques destinées à optimiser les flux de travail de biopsie par fusion IRM et à soutenir le développement de la thérapie focale dans la prise en charge du cancer de la prostate
12/03/2026
GRENOBLE, France, 12 mars 2026 (GLOBE NEWSWIRE) -- Koelis, SAS (« Koelis » ou la « Société », www.koelis.com ), leader technologique et acteur innovant dans le domaine du guidage par fusion IRM-échographie appliqué aux [...]
Sanofi: Information concerning the total number of voting rights and shares - February 2026
12/03/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Rakovina Therapeutics Announces Extension of Non-Brokered Private Placement
12/03/2026
VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through [...]
Amoéba receives its first order from Koppert and confirms its transformation into a commercial company
12/03/2026
Chassieu, March 12, 2026 (GLOBE NEWSWIRE) -- Amoéba receives its first order from Koppert and confirms its transformation into a commercial company Chassieu (France), 11 March 2026 – 6:00 pm - Amoéba (FR0011051598 - [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
12/03/2026
Please see enclosed pdf. Attachment 12032026_trading_in_shares_ALS
Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference
12/03/2026
CINCINNATI, March 12, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 36th Annual Healthcare Conference on Thursday, March 19, 2026, [...]
HealthEx Partners with Microsoft to Bring Consumers’ Personal Health History to Copilot Health
12/03/2026
Partnership combines digital identity, comprehensive health records, and consent infrastructure to power Microsoft’s new personalized, AI-powered health insights LAS VEGAS, March 12, 2026 (GLOBE NEWSWIRE) -- HIMSS [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 11 mars 2026
12/03/2026
Nombre total de droits de vote et d’actions composant le capital social au 11 mars 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
Cloudcure Launches Companion App to Close Clinical Adherence Gap in Metabolic Health
12/03/2026
Toronto, ON, March 12, 2026 (GLOBE NEWSWIRE) -- Cloudcure, a specialized health platform dedicated to improving metabolic health through evidence-based, personalized medicine, has announced the launch of its new weight [...]
Serotonin Centers Introduces New Medical Longevity Model for the Fitness Industry
12/03/2026
Turnkey partner platform brings medically supervised weight loss, hormone optimization and longevity services into gyms and health clubs nationwide ORLANDO, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Serotonin Centers [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 11, 2026
12/03/2026
Disclosure of Share Capital and Voting Rights Outstanding as of March 11, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers
12/03/2026
New Appointments Bring Deep Expertise in Immunology and Infectious Disease to Advance IND Submission and Intellectual Property Strategy Jericho, New York, March 12, 2026 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc [...]
Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy
12/03/2026
Reduced progression of myocardial fibrosis measured by LGE on cardiac MRI (p=0.022) Significant improvement in LVEF versus placebo in patients with baseline cardiomyopathy (p=0.017) Global Statistical Test (GST) [...]
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
12/03/2026
CNTY-813, lead beta islet cell therapy program as a potential functional cure for type 1 diabetes, in Investigational New Drug (IND)-enabling studies; IND submission expected in 4Q 2026 to support anticipated initial [...]
ORYZON Expands Patent Protection for Iadademstat with Grant Decision in Mexico Covering Combinations with PD-1/PD-L1 Inhibitors
12/03/2026
Key combination for the treatment of Small Cell Lung Cancer MADRID and CAMBRIDGE, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical [...]
PracticeLink Launches 2026 Webinar Series for Healthcare Recruiters
12/03/2026
ST. LOUIS and HINTON, West Virginia, March 12, 2026 (GLOBE NEWSWIRE) -- PracticeLink , the nation’s most trusted physician recruitment resource and home of the most widely used online physician job board, is pleased to [...]
Theriva™ Biologics Reports Full-Year 2025 Operational Highlights and Financial Results
12/03/2026
- Advancing clinical development of VCN-01 for pancreatic ductal adenocarcinoma and retinoblastoma - - Licensed SYN-020 to Rasayana Therapeutics for development in multiple indications; up to $38 million in potential [...]
Milestone Pharmaceuticals to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 20, 2026
12/03/2026
Conference Call and Webcast Scheduled for Friday, March 20 at 8:30am ET MONTREAL and CHARLOTTE, N.C., March 12, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that it will report [...]

Pages